Neutrophilic drug reactions

Clin Dermatol. 2020 Nov-Dec;38(6):648-659. doi: 10.1016/j.clindermatol.2020.06.012. Epub 2020 Jul 5.

Abstract

Neutrophilic drug reactions are unique eruptions that can affect hospitalized patients and share a common pathophysiology with neutrophils as the key mediators of inflammation. They range in clinical presentation from papules and plaques to bullae and erosions to pustules. Although there is some overlap in presentation, each has distinguishing features that aid the clinician in differentiation from one another and from other drug hypersensitivity reactions. Much of the data on these reactions are from case reports and series or retrospective review studies. There are limited prospective observational studies dedicated to these adverse drug reactions. We review the more common and life-threatening neutrophilic drug reactions, their proposed mechanism of action, and their management.

Publication types

  • Review

MeSH terms

  • Drug Eruptions / diagnosis
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Drug Eruptions / therapy
  • Drug Hypersensitivity / diagnosis
  • Drug Hypersensitivity / etiology*
  • Drug Hypersensitivity / pathology
  • Drug Hypersensitivity / therapy
  • Drug-Related Side Effects and Adverse Reactions*
  • Exanthema
  • Female
  • Halogens / adverse effects
  • Hidradenitis
  • Humans
  • Immunoglobulin A
  • Male
  • Neutrophils* / immunology
  • Panniculitis
  • Pharmaceutical Preparations*
  • Pyoderma Gangrenosum
  • Skin Diseases, Vesiculobullous
  • Sweet Syndrome

Substances

  • Halogens
  • Immunoglobulin A
  • Pharmaceutical Preparations